T Cell Invigoration is Associated with the Clinical Response to Anti-PD-1-Based Immunotherapy in Non-Small Cell Lung Cancer.

Wu, Hui; Weng, Gui Zhen; Sun, Li Na; Pan, Zhang Chi; Zhang, Lu; Chen, Qiang; Shi, Chun Mei.

Afiliación

Wu H; Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, People's Republic of China.
Weng GZ; Department of Oncology, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, Zhejiang, 323000, People's Republic of China.
Sun LN; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, 350001, People's Republic of China.
Pan ZC; Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, People's Republic of China.
Zhang L; Department of Oncology, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, Zhejiang, 323000, People's Republic of China.
Chen Q; Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, People's Republic of China.
Shi CM; Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China.

Cancer Manag Res ; 15: 1141-1153, 2023.

Article en En | MEDLINE | ID: mdl-37842130